165 related articles for article (PubMed ID: 37935108)
1. Referral, Uptake, and Outcome of Genetic Counseling and Testing in Patients With Early-Onset Colorectal Cancer.
Syed H; Sommovilla J; Burke CA; McGee S; Macaron C; Heald B; Lyu R; Schmit SL; Nair K; Kamath S; Krishnamurthi S; Khorana AA; Liska D
J Natl Compr Canc Netw; 2023 Nov; 21(11):1156-1163.e5. PubMed ID: 37935108
[TBL] [Abstract][Full Text] [Related]
2. Completion of Genetic Testing and Incidence of Pathogenic Germline Mutation among Patients with Early-Onset Colorectal Cancer: A Single Institution Analysis.
Storandt MH; Rogen KR; Iyyangar A; Schnell RR; Mitchell JL; Hubbard JM; Sinicrope FA; Jatoi A; Mahipal A; Shi Q; Jin Z
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509234
[TBL] [Abstract][Full Text] [Related]
3. Clinical Multigene Panel Testing Identifies Racial and Ethnic Differences in Germline Pathogenic Variants Among Patients With Early-Onset Colorectal Cancer.
Seagle HM; Keller SR; Tavtigian SV; Horton C; Holowatyj AN
J Clin Oncol; 2023 Sep; 41(26):4279-4289. PubMed ID: 37319387
[TBL] [Abstract][Full Text] [Related]
4. The Inherited and Familial Component of Early-Onset Colorectal Cancer.
Daca Alvarez M; Quintana I; Terradas M; Mur P; Balaguer F; Valle L
Cells; 2021 Mar; 10(3):. PubMed ID: 33806975
[TBL] [Abstract][Full Text] [Related]
5. Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective Study.
Uson PLS; Riegert-Johnson D; Boardman L; Kisiel J; Mountjoy L; Patel N; Lizaola-Mayo B; Borad MJ; Ahn D; Sonbol MB; Jones J; Leighton JA; Gurudu S; Singh H; Klint M; Kunze KL; Golafshar MA; Esplin ED; Nussbaum RL; Stewart AK; Bekaii-Saab TS; Jewel Samadder N
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e508-e528. PubMed ID: 33857637
[TBL] [Abstract][Full Text] [Related]
6. Uptake of genetic counseling and testing in a clinic-based population of women with breast cancer.
Wehbe A; Manning M; Assad H; Purrington KS; Simon MS
Cancer Med; 2022 Sep; 11(17):3304-3311. PubMed ID: 35322585
[TBL] [Abstract][Full Text] [Related]
7. DNA Mismatch Repair-Deficient Colorectal Carcinoma: Referral Rate for Genetic Cancer Risk Assessment in a Brazilian Cancer Center.
Gomes AAD; Macedo MP; Torrezan GT; Zenun GR; Aguiar S; Begnami MD; Carraro DM; Formiga MN
J Gastrointest Cancer; 2021 Sep; 52(3):997-1002. PubMed ID: 32974876
[TBL] [Abstract][Full Text] [Related]
8. Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With Colorectal Cancer.
Coughlin SE; Heald B; Clark DF; Nielsen SM; Hatchell KE; Esplin ED; Katona BW
JCO Precis Oncol; 2022 Nov; 6():e2200517. PubMed ID: 36370464
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Early-Onset Colorectal Cancer.
Low EE; Demb J; Liu L; Earles A; Bustamante R; Williams CD; Provenzale D; Kaltenbach T; Gawron AJ; Martinez ME; Gupta S
Gastroenterology; 2020 Aug; 159(2):492-501.e7. PubMed ID: 31926997
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Genetic Characteristics of Colorectal Cancer in Persons under 50 Years of Age: A Review.
Strum WB; Boland CR
Dig Dis Sci; 2019 Nov; 64(11):3059-3065. PubMed ID: 31055721
[TBL] [Abstract][Full Text] [Related]
11. Hereditary evaluation and genetic counselling in young individuals with colorectal cancer in a population-based cohort.
Lundqvist E; Kuchinskaya E; Landerholm K; Assarsson J; Benckert A; Myrelid P; Haapaniemi S
Surg Oncol; 2022 May; 41():101741. PubMed ID: 35325783
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and clinical characteristics of early-onset colorectal cancer vs. late-onset colorectal cancer: a case-case study.
Di Leo M; Zuppardo RA; Puzzono M; Ditonno I; Mannucci A; Antoci G; Russo Raucci A; Patricelli MG; Elmore U; Tamburini AM; Albarello L; Azzolini F; Bonura GF; Esposito D; Fanti L; Notaristefano C; Viale E; Perea J; Testoni PA; Rosati R; Cavestro GM
Eur J Gastroenterol Hepatol; 2021 Sep; 33(9):1153-1160. PubMed ID: 33208680
[TBL] [Abstract][Full Text] [Related]
13. Adherence to guidelines for the referral of patients with colorectal cancer and abnormal tumour tissue testing for assessment of Lynch syndrome.
Han J; Spigelman AD
ANZ J Surg; 2019 Oct; 89(10):1281-1285. PubMed ID: 30856687
[TBL] [Abstract][Full Text] [Related]
14. Unexpected actionable genetic variants revealed by multigene panel testing of patients with uterine cancer.
Heald B; Mokhtary S; Nielsen SM; Rojahn S; Yang S; Michalski ST; Esplin ED
Gynecol Oncol; 2022 Aug; 166(2):344-350. PubMed ID: 35691755
[TBL] [Abstract][Full Text] [Related]
15. Germline Genetic Features of Young Individuals With Colorectal Cancer.
Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors for preneoplastic and neoplastic lesions of the colon and rectum in patients under 50 referred for colonoscopy.
Agazzi S; Lenti MV; Klersy C; Strada E; Pozzi L; Rovedatti L; Bardone M; Mauro A; Costetti M; Costa S; De Grazia F; Di Sabatino A
Eur J Intern Med; 2021 May; 87():36-43. PubMed ID: 33610414
[TBL] [Abstract][Full Text] [Related]
17. Low Referral Rate for Genetic Testing in Racially and Ethnically Diverse Patients Despite Universal Colorectal Cancer Screening.
Muller C; Lee SM; Barge W; Siddique SM; Berera S; Wideroff G; Tondon R; Chang J; Peterson M; Stoll J; Katona BW; Sussman DA; Melson J; Kupfer SS
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1911-1918.e2. PubMed ID: 30130624
[TBL] [Abstract][Full Text] [Related]
18. Value of database linkage: are patients at risk of familial colorectal cancer being referred for genetic counselling and testing?
Wong C; Gibbs P; Johns J; Jones I; Faragher I; Lynch E; Macrae F; Lipton L
Intern Med J; 2008 May; 38(5):328-33. PubMed ID: 17916174
[TBL] [Abstract][Full Text] [Related]
19. Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.
Walker EJ; Carnevale J; Pedley C; Blanco A; Chan S; Collisson EA; Tempero MA; Ko AH
Fam Cancer; 2019 Apr; 18(2):241-251. PubMed ID: 30267352
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical Agents as Potential Drivers in the Development of Early-Onset Colorectal Cancer: Case-Control Study.
Ben-Aharon I; Rotem R; Melzer-Cohen C; Twig G; Cercek A; Half E; Goshen-Lago T; Chodik G; Kelsen D
JMIR Public Health Surveill; 2023 Dec; 9():e50110. PubMed ID: 37933755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
